Article

Should Drug Approval Decisions Consider Cost?

A newly approved cystic fibrosis drug has an annual wholesale cost of $259,000.

A newly approved cystic fibrosis drug has an annual wholesale cost of $259,000.

J.PMorgan Chase estimated that global sales of this drug could teach $1.6 billion next year and $4.2 billion by 2020. That's a lot of money for a medication that some members of an FDA advisory committee believed had modest effectiveness.

This drug’s hefty price tag raises a few questions, including:

  • How long can our health care system sustain high prices for drug that only benefit a small number of patients?
  • Will some type of drug rationing result from the high costs?
  • Will there be legislation that requires drug approvals based on cost effectiveness?

What do you think?

Related Videos
Pharmacist assisting a patient with pericarditis -- Image credit: Yuri Arcurs/peopleimages.com | stock.adobe.com
Patient receiving diabetes consultation -- Image credit: Syda Productions | stock.adobe.com
California Wildfires, Pharmacies, Community | image Credit: J Bettencourt/peopleimages.com | stock.adobe.com
California Wildfire, Pharmacy, Community | Image Credit: Erin | stock.adobe.com
Allergies, Asthma, Biologic Treatment, Pharmacists | Image Credit: Pixel-Shot | stock.adobe.com
Woman professional nutritionist checking dietary supplements in hand, surrounded by a variety of fruits, nuts, vegetables, and dietary supplements on the table - Image credit: amenic181 | stock.adobe.com